The effect of transforming growth factor-β1 on nasopharyngeal carcinoma cells: insensitive to cell growth but functional to TGF-β/Smad pathway

被引:17
作者
Xiao, Jian [2 ]
Xiang, Qi [1 ]
Xiao, Ye-Chen [1 ]
Su, Zhi-Jian [1 ]
Huang, Zhi-Feng [2 ]
Zhang, Qi-Hao [1 ]
Tan, Yi [2 ]
Li, Xiao-Kun [2 ]
Huang, Ya-Dong [1 ]
机构
[1] Jinan Univ, Biopharmaceut Res & Dev Ctr, Guangzhou 510632, Guangdong, Peoples R China
[2] Wenzhou Med Coll, Sch Pharm, Wenzhou 325035, Peoples R China
基金
中国国家自然科学基金;
关键词
BETA SIGNALING PATHWAY; SMAD4; GENE-MUTATIONS; EXPRESSION; TGF-BETA-1; TRANSFORMING-GROWTH-FACTOR-BETA-1; ASSOCIATION; ACTIVATION; RECEPTORS;
D O I
10.1186/1756-9966-29-35
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: This study explored the response of nasopharyngeal carcinoma cells to TGF-beta 1-induced growth suppression and investigated the roles of the TGF-beta/Smad signaling pathway in nasopharyngeal carcinoma cells. Methods: The cells of nasopharyngeal carcinoma cell line CNE2 were treated with TGF-beta 1. The growth responses of CNE2 cells were analyzed by MTT assay. The mRNA expression and protein subcellular localization of the TGF-beta/Smad signaling components in the CNE2 were determined by real time RT-PCR and immunocytochemical analysis. Results: We found that the growth of CNE2 cells was not suppressed by TGF-beta 1. The signaling proteins T beta RII, Smad 7 were expressed normally, while Smad2, Smad3, and Smad4 increased significantly at the mRNA level. TGF-beta type II receptor and Smad7 had no change compared to the normal nasopharyngeal epithelial cells. In addition, Smad2 was phosphorylated to pSmad2, and the activated pSmad2 translocated into the nucleus from the cytoplasm, while the inhibitory Smad-Smad7 translocated from the nucleus to the cytoplasm after TGF-beta 1 stimulation. Conclusion: The results suggested that CNE2 cells are not sensitive to growth suppression by TGF-beta 1, but the TGF-beta/mad signaling transduction is functional. Further work is needed to address a more detailed spectrum of the TGF-beta/Smad signaling pathway in CNE2 cells.
引用
收藏
页数:8
相关论文
共 42 条
[1]   Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: Current status [J].
Afqir, Said ;
Ismaili, Nabil ;
Errihani, Hassan .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2009, 5 (01) :3-7
[2]   TGF-β1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer [J].
Araki, Shinako ;
Eitel, Jacob A. ;
Batuello, Christopher N. ;
Bijangi-Vishehsaraei, Khadijeh ;
Xie, Xian-Jin ;
Danielpour, David ;
Pollok, Karen E. ;
Boothman, David A. ;
Mayo, Lindsey D. .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (01) :290-302
[3]   SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer [J].
Blackford, Amanda ;
Serrano, Oscar K. ;
Wolfgang, Christopher L. ;
Parmigiani, Giovanni ;
Jones, Sian ;
Zhang, Xiaosong ;
Parsons, D. Williams ;
Lin, Jimmy Cheng-Ho ;
Leary, Rebecca J. ;
Eshleman, James R. ;
Goggins, Michael ;
Jaffee, Elizabeth M. ;
Iacobuzio-Donahue, Christine A. ;
Maitra, Anirban ;
Cameron, John L. ;
Olino, Kelly ;
Schulick, Richard ;
Winter, Jordan ;
Herman, Joseph M. ;
Laheru, Daniel ;
Klein, Alison P. ;
Vogelstein, Bert ;
Kinzler, Kenneth W. ;
Velculescu, Victor E. ;
Hruban, Ralph H. .
CLINICAL CANCER RESEARCH, 2009, 15 (14) :4674-4679
[4]   TGF-beta signaling in breast cancer [J].
Buck, Miriam B. ;
Knabbe, Cornelius .
ESTROGENS AND HUMAN DISEASES, 2006, 1089 :119-126
[5]  
Cao DF, 2008, INT J CLIN EXP PATHO, V1, P510
[6]  
Cardillo MR, 2000, ANAL QUANT CYTOL, V22, P403
[7]   Change of plasma transforming growth factor-β1 levels in nasopharyngeal carcinoma patients treated with concurrent chemo-radiotherapy [J].
Chen, HW ;
Chang, YC ;
Lai, YL ;
Chen, YJ ;
Huang, MJ ;
Leu, YS ;
Fu, YK ;
Wang, LW ;
Hwang, JJ .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (08) :427-432
[8]  
Chen Shuang-ling, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P305
[9]  
Coban S, 2007, HEPATO-GASTROENTEROL, V54, P1472
[10]   The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain [J].
de Caestecker, MP ;
Yahata, T ;
Wang, D ;
Parks, WT ;
Huang, SX ;
Hill, CS ;
Shioda, T ;
Roberts, AB ;
Lechleider, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) :2115-2122